Yoshiki Imamura

Prof. Yoshiki Imamura


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2019 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
YIYoshiki Imamura
Yoshiki Imamura
TSTakahiro Shinozaki
Takahiro Shinozaki
AOAkiko Okada‐Ogawa
Akiko Okada‐Ogawa
NNNoboru Noma
Noboru Noma
MSMasahiro Shinoda
Masahiro Shinoda
PSPeter Svensson
Peter Svensson

Verified
Journal Article
Open access
PDF file
SASayaka Asano
Sayaka Asano
YHYoshinori Hayashi
Yoshinori Hayashi
KIKoichi Iwata
Koichi Iwata
AOAkiko Okada-Ogawa
Akiko Okada-Ogawa
HSHitomi suzuro
Hitomi suzuro
Masamichi ShinodaMasamichi Shinoda
Masamichi Shinoda
Trigeminal nerve injury causes a distinct time window of glial activation in the trigeminal spinal subnucleus caudalis (Vc), which are involved in the initiation and maintenance phases of orofacial neuropathic pain. Microglia-derived factors enable the activation of astrocytes. The complement component C1q, which promotes the activation of astrocytes, is known to be synthesized in microglia. However, it is unclear whether microglia–astrocyte communication via C1q is involved in orofacial neuropathic pain. Here, we analyzed microglia-astrocyte communication in a rat model with infraorbital nerve injury (IONI). The orofacial mechanical hypersensitivity induced by IONI was significantly attenuated by preemptive treatment with minocycline. Immunohistochemical analyses revealed that minocycline inhibited the increase in c-Fos immune-reactive (IR) cells and the fluorescence intensity of both Iba1 and glial fibrillary acidic protein (GFAP) in the Vc following IONI. Intracisternal administration of C1q caused orofacial mechanical hypersensitivity and an increase in the number of c-Fos-IR cells and fluorescence intensity of GFAP. C1q-induced orofacial mechanical hypersensitivity was completely abrogated by intracisternal administration of fluorocitrate. The present findings suggest that the enhancement in the excitability of Vc nociceptive neurons is produced by astrocytic activation via the signaling of C1q released from activated microglia in the Vc following IONI, resulting in persistent orofacial neuropathic pain.

27 December 2023 in Journal of Oral Rehabilitation
Verified
Journal Article
Open access
JDJustin Durham
Justin Durham
RORichard Ohrbach
Richard Ohrbach
LBLene Baad‐Hansen
Lene Baad‐Hansen
SDStephen Davies
Stephen Davies
ALAntoon De Laat
Antoon De Laat
IMI Nf O R M
I Nf O R M
Background: Despite advances in temporomandibular disorders' (TMDs) diagnosis, the diagnostic process continues to be problematic in non‐specialist settings.Objective: To complete a Delphi process to shorten the Diagnostic Criteria for TMD (DC/TMD) to a brief DC/TMD (bDC/TMD) for expedient clinical diagnosis and initial management.Methods: An international Delphi panel was created with 23 clinicians representing major specialities, general dentistry and related fields. The process comprised a full day workshop, seven virtual meetings, six rounds of electronic discussion and finally an open consultation at a virtual international symposium.Results: Within the physical axis (Axis 1), the self‐report Symptom Questionnaire of the DC/TMD did not require shortening from 14 items for the bDC/TMD. The compulsory use of the TMD pain screener was removed reducing the total number of Axis 1 items by 18%. The DC/TMD Axis 1 10‐section examination protocol (25 movements, up to 12 sets of bilateral palpations) was reduced to four sections in the bDC/TMD protocol involving three movements and three sets of palpations. Axis I then resulted in two groups of diagnoses: painful TMD (inclusive of secondary headache), and common joint‐related TMD with functional implications. The psychosocial axis (Axis 2) was shortened to an ultra‐brief 11 item assessment.Conclusion: The bDC/TMD represents a substantially reduced and likely expedited method to establish (grouping) diagnoses in TMDs. This may provide greater utility for settings requiring less granular diagnoses for the implementation of initial treatment, for example non‐specialist general dental practice.

5 November 2020 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
CCCharlotte Currie
Charlotte Currie
RORichard Ohrbach
Richard Ohrbach
RLReny De Leeuw
Reny De Leeuw
HFHeli Forssell
Heli Forssell
YIYoshiki Imamura
Yoshiki Imamura
JDJustin Durham
Justin Durham

20 July 2016 in Journal of Dental Research
Verified
Journal Article
Closed access
TST. Shinozaki
T. Shinozaki
YIYoshiki Imamura
Yoshiki Imamura
RKR. Kohashi
R. Kohashi
KDK. Dezawa
K. Dezawa
YNY. Nakaya
Y. Nakaya
MTM. Taira
M. Taira
Burning mouth syndrome (BMS) is an idiopathic orofacial pain condition. Although the pathophysiology of BMS is not clearly understood, central and peripheral neuropathic mechanisms are thought to be involved. The authors compared brain response to noxious heat stimuli in 16 right-handed women with primary BMS and 15 sex- and age-matched right-handed healthy female controls. A thermal stimulus sequence of 32 °C to 40 °C to 32 °C to 49 °C was repeated 4 times in a cycle. Warm and noxious heat stimuli were delivered with a Peltier thermode placed on the right palm or right lower lip for 32 s each in a session. Functional magnetic resonance imaging data were obtained by recording echoplanar images with a block design. Statistical Parametric Mapping 8 software was used to analyze the data. Patients and controls both reported feeling more pain during palm stimulation than during lip stimulation. Repetition of noxious heat stimulus on the lower lip but not on the palm induced habituation in brain activity in the cingulate cortex without reduction in pain perception. Multiple regression analysis revealed a correlation between perceived pain intensity and suppression of brain activity in the anterior cingulate cortex when the repeated thermal sequence was applied at the lower lip. Furthermore, the response of the parahippocampal area differed in BMS patients and controls when the same repeated thermal sequence was applied at the palm. The authors’ findings indicate that BMS patients show specific brain responses due to impaired function of the central and peripheral nervous systems (clinical trial registration: UMIN000015002).

2 September 2021 in Journal of Dental Sciences
Verified
Journal Article
Open access
KOKana Ozasa
Kana Ozasa
NNNoboru Noma
Noboru Noma
AYAndrew Young
Andrew Young
OKOlga Korczeniewska
Olga Korczeniewska
EEEli Eliav
Eli Eliav
YIYoshiki Imamura
Yoshiki Imamura
Burning mouth syndrome (BMS) is a chronic condition presenting as intraoral burning or dysesthesia, with a high preponderance in menopausal women. This study aimed to examine the association between somatosensory dysfunction and BMS in premenopausal, early postmenopausal, and late postmenopausal patients, using a standardized Quantitative Sensory Testing (QST) protocol, and to determine the predictive value of thermal or mechanical perception by QST for detecting BMS. An observational case–control study was performed with 36 female participants with BMS (12 premenopausal, 10 early postmenopausal, and 14 late postmenopausal) and 42 age- and sex-matched healthy volunteers (21 premenopausal, 10 early postmenopausal, and 11 late postmenopausal). Neurophysiological tests were used to evaluate somatosensory dysfunction at the tongue. Z-score in the late postmenopausal BMS group revealed a gain of function for the cold pain threshold and heat pain threshold (Z = 2.08 and 3.38, respectively). In the multiple regression analysis with the Visual Analog Scale as the dependent variable, the vibration detection threshold predicted the severity of burning mouth sensation in the premenopausal group. Late postmenopausal patients with BMS showed an increased response of the tongue to noxious thermal stimuli. This supports the theory that changes in sex hormones may affect trigeminal somatosensory function, particularly during the late postmenopausal stage in patients with BMS.